Volume 13, Number 9—September 2007
Dispatch
Rickettsia monacensis and Human Disease, Spain
Isabel Jado*, José A. Oteo†, Mikel Aldámiz‡, Horacio Gil*, Raquel Escudero*, Valvanera Ibarra†, Joseba Portu‡, Aranzazu Portillo†, María J. Lezaun‡, Cristina García-Amil*, Isabel Rodríguez-Moreno*, and Pedro Anda*
Table
Microimmunofluorescence titers obtained with different rickettsial antigens, 2 patients, northern Spain, 2003*
| Patient | Week† | Rickettsia conorii | R. monacensis | R. helvetica | R. akari | R. australis |
|---|---|---|---|---|---|---|
| 1 | 1 | <1:40 | <40 | <40 | <40 | <40 |
| 4 | 1,280 | 2,560 | 2,560 | 1,280 | 640 | |
| 13 | 1,280 | 1,280 | 1,280 | 1,280 | 1,280 | |
| 26 |
1,280 |
1,280 |
1,280 |
320 |
320 |
|
| 2 | 1 | 640 | 2,560 | 2,560 | 640 | 320 |
| 4 | 320 | 1,280 | 1,280 | 320 | 160 | |
| 6 | 640 | 1,280 | 1,280 | 320 | 160 |
*A 1-fold decrease in titer is considered not significant.
†Week after symptom onset in which the samples were extracted.
Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.